Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 2/2018

01-05-2018 | Original Article

Thrombolysis for stroke in Ireland: increasing access and maintaining safety in a challenging environment

Authors: P. McElwaine, J. McCormack, C. Brennan, H. Coetzee, P. Cotter, R. Doyle, A. Hickey, F. Horgan, C. Loughnane, C. Macey, P. Marsden, D. McCabe, R. Mulcahy, I. Noone, E. Shelley, T. Stapleton, D. Williams, P. Kelly, J. Harbison

Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2018

Login to get access

Abstract

Background

In the setting of a national audit of acute stroke services, we examined the delivery of thrombolytic therapy for ischaemic stroke and whether current practice was achieving safe outcomes and consistent delivery for patients.

Method

Data obtained from the recent national stroke audit was compared against previous Irish audit, the most recent SSNAP UK stroke audit and the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) study.

Results

Thrombolysis was provided in 27 acute hospitals throughout Ireland during the period assessed with 82% (22/27) providing 24/7 access, the remaining sites using redirect policies. Decision to thrombolyse was made by stroke trained consultants in 63% (17/27) of units, with general physicians and emergency medicine consultants covering the other units. Thrombolysis rate for non-haemorrhagic stroke was 11% (n = 80/742, CI 95% ±2.23) versus a 1% rate in the 2008 audit. Sites receiving patients through a redirect policy had the highest thrombolysis rate, an average of 24%. Nearly 30% of cases were thrombolysed on the weekend. Eighty-three percent of cases were managed in a stroke unit at some time during admission versus 54% of the national total cases. Thirty-seven percent of patients were ≥80 years old. The mortality rate was 11.3% versus the national mortality rate for non-thrombolysed ischaemic strokes of 10% (p > 0.5), and this is comparable to the SITS-MOST 2007 study 3-month mortality rate of 11.3% (p > 0.5).

Conclusion

Stroke thrombolysis is being effectively and safely provided in acute stroke services in Ireland despite regular involvement of non-specialist staff. There is still potential to improve thrombolysis rate.
Appendix
Available only for authorised users
Literature
1.
go back to reference Disorders TNIoN, Group Sr-PSS (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333(24):1581–1588CrossRef Disorders TNIoN, Group Sr-PSS (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333(24):1581–1588CrossRef
2.
go back to reference Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W et al Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369(9558):275–282 Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W et al Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369(9558):275–282
3.
go back to reference Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317–1329CrossRefPubMed Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317–1329CrossRefPubMed
4.
go back to reference Horgan F, Murphy S, Hickey A, McGee H, O'Neill D (2009) Results from the first Irish National Audit of Stroke Care (INASC)—clinical audit. Cerebrovasc Dis 27:228 Horgan F, Murphy S, Hickey A, McGee H, O'Neill D (2009) Results from the first Irish National Audit of Stroke Care (INASC)—clinical audit. Cerebrovasc Dis 27:228
5.
go back to reference Health Do. Changing cardiovascular health: National Cardiovascular Health Policy 2010-2019. Government Publications, 2010–05. Report No.: 0-7557-7639-9 Health Do. Changing cardiovascular health: National Cardiovascular Health Policy 2010-2019. Government Publications, 2010–05. Report No.: 0-7557-7639-9
7.
go back to reference McElwaine P, McCormack J, Harbison J. National Stroke Audit 2015. Irish Heart Foundation (IHF) & Health Service Executive, 2016-02. Report No.: 978-1-78602-006-2 McElwaine P, McCormack J, Harbison J. National Stroke Audit 2015. Irish Heart Foundation (IHF) & Health Service Executive, 2016-02. Report No.: 978-1-78602-006-2
8.
go back to reference Lees KR, Ford GA, Muir KW, Ahmed N, Dyker AG, Atula S et al (2008) Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register. QJM 101(11):863–869CrossRefPubMed Lees KR, Ford GA, Muir KW, Ahmed N, Dyker AG, Atula S et al (2008) Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register. QJM 101(11):863–869CrossRefPubMed
9.
go back to reference Scherf S, Limburg M, Wimmers R, Middelkoop I, Lingsma H (2016) Increase in national intravenous thrombolysis rates for ischaemic stroke between 2005 and 2012: is bigger better? BMC Neurol 16(1):1–6CrossRef Scherf S, Limburg M, Wimmers R, Middelkoop I, Lingsma H (2016) Increase in national intravenous thrombolysis rates for ischaemic stroke between 2005 and 2012: is bigger better? BMC Neurol 16(1):1–6CrossRef
10.
go back to reference Hillmann S, Wiedmann S, Fraser A, Baeza J, Rudd A, Norrving B et al (2015) Temporal changes in the quality of acute stroke care in five national audits across Europe. Biomed Res Int 2015:432497CrossRefPubMedPubMedCentral Hillmann S, Wiedmann S, Fraser A, Baeza J, Rudd A, Norrving B et al (2015) Temporal changes in the quality of acute stroke care in five national audits across Europe. Biomed Res Int 2015:432497CrossRefPubMedPubMedCentral
11.
go back to reference Price CI, Clement F, Gray J, Donaldson C, Ford GA (2009) Systematic review of stroke thrombolysis service configuration. Expert Rev Neurother 9(2):211–233CrossRefPubMed Price CI, Clement F, Gray J, Donaldson C, Ford GA (2009) Systematic review of stroke thrombolysis service configuration. Expert Rev Neurother 9(2):211–233CrossRefPubMed
13.
go back to reference Wahlgren N, Moreira T, Michel P, Steiner T, Jansen O, Cognard C et al (2016) Mechanical thrombectomy in acute ischemic stroke: consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN. Int J Stroke 11(1):134–147CrossRefPubMed Wahlgren N, Moreira T, Michel P, Steiner T, Jansen O, Cognard C et al (2016) Mechanical thrombectomy in acute ischemic stroke: consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN. Int J Stroke 11(1):134–147CrossRefPubMed
14.
go back to reference Ringelstein EB, Chamorro A, Kaste M, Langhorne P, Leys D, Lyrer P et al (2013) European Stroke Organisation recommendations to establish a stroke unit and stroke center. Stroke 44(3):828–840CrossRefPubMed Ringelstein EB, Chamorro A, Kaste M, Langhorne P, Leys D, Lyrer P et al (2013) European Stroke Organisation recommendations to establish a stroke unit and stroke center. Stroke 44(3):828–840CrossRefPubMed
15.
go back to reference Rudd AG, Irwin P, Rutledge Z, Lowe D, Wade D, Morris R et al (1999) The national sentinel audit for stroke: a tool for raising standards of care. J R Coll Physicians Lond 33(5):460–464PubMed Rudd AG, Irwin P, Rutledge Z, Lowe D, Wade D, Morris R et al (1999) The national sentinel audit for stroke: a tool for raising standards of care. J R Coll Physicians Lond 33(5):460–464PubMed
16.
go back to reference The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 379(9834):2352–63 The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 379(9834):2352–63
17.
go back to reference Anderson CS, Robinson T, Lindley RI, Arima H, Lavados PM, Lee T-H, et al. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N Engl J Med 0(0):null Anderson CS, Robinson T, Lindley RI, Arima H, Lavados PM, Lee T-H, et al. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N Engl J Med 0(0):null
Metadata
Title
Thrombolysis for stroke in Ireland: increasing access and maintaining safety in a challenging environment
Authors
P. McElwaine
J. McCormack
C. Brennan
H. Coetzee
P. Cotter
R. Doyle
A. Hickey
F. Horgan
C. Loughnane
C. Macey
P. Marsden
D. McCabe
R. Mulcahy
I. Noone
E. Shelley
T. Stapleton
D. Williams
P. Kelly
J. Harbison
Publication date
01-05-2018
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2018
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-017-1661-5

Other articles of this Issue 2/2018

Irish Journal of Medical Science (1971 -) 2/2018 Go to the issue